Ascletis Pharma, Inc. (ASCLF)
1.35
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Ascletis Pharma EPS Diluted (TTM) : -0.0517 for Dec. 31, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| December 31, 2025 | -0.0517 |
| June 30, 2025 | -0.0366 |
| December 31, 2024 | -0.0418 |
| June 30, 2024 | -0.0343 |
| December 31, 2023 | -0.0187 |
| June 30, 2023 | -0.0321 |
| December 31, 2022 | -0.0424 |
| June 30, 2022 | -0.0251 |
| December 31, 2021 | -0.0282 |
| June 30, 2021 | -0.0368 |
| Date | Value |
|---|---|
| December 31, 2020 | -0.0282 |
| June 30, 2020 | -0.0133 |
| December 31, 2019 | -0.0129 |
| June 30, 2019 | -0.012 |
| December 31, 2018 | -0.0006 |
| June 30, 2018 | 0.0048 |
| December 31, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| CStone Pharmaceuticals Co. Ltd. | -0.0442 |
| RemeGen Co., Ltd. | -0.1782 |
| InnoCare Pharma Ltd. | 0.0588 |
| Adagene, Inc. | -0.3743 |
| Akeso, Inc. | -0.1715 |